KR101307910B1 - 여드름 치료를 위한 아다만틸 메톡시다이페닐 프로페노산의용도 - Google Patents

여드름 치료를 위한 아다만틸 메톡시다이페닐 프로페노산의용도 Download PDF

Info

Publication number
KR101307910B1
KR101307910B1 KR1020077027137A KR20077027137A KR101307910B1 KR 101307910 B1 KR101307910 B1 KR 101307910B1 KR 1020077027137 A KR1020077027137 A KR 1020077027137A KR 20077027137 A KR20077027137 A KR 20077027137A KR 101307910 B1 KR101307910 B1 KR 101307910B1
Authority
KR
South Korea
Prior art keywords
acne
mice
treatment
skin
lecithin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020077027137A
Other languages
English (en)
Korean (ko)
Other versions
KR20080016573A (ko
Inventor
클라우디오 피사노
로레다나 베시
Original Assignee
시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. filed Critical 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Publication of KR20080016573A publication Critical patent/KR20080016573A/ko
Application granted granted Critical
Publication of KR101307910B1 publication Critical patent/KR101307910B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
KR1020077027137A 2005-05-20 2006-05-05 여드름 치료를 위한 아다만틸 메톡시다이페닐 프로페노산의용도 Expired - Fee Related KR101307910B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2005A000248 2005-05-20
IT000248A ITRM20050248A1 (it) 2005-05-20 2005-05-20 Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee.
PCT/EP2006/062088 WO2006122883A1 (en) 2005-05-20 2006-05-05 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne

Publications (2)

Publication Number Publication Date
KR20080016573A KR20080016573A (ko) 2008-02-21
KR101307910B1 true KR101307910B1 (ko) 2013-09-16

Family

ID=36646157

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077027137A Expired - Fee Related KR101307910B1 (ko) 2005-05-20 2006-05-05 여드름 치료를 위한 아다만틸 메톡시다이페닐 프로페노산의용도

Country Status (13)

Country Link
US (1) US7635719B2 (https=)
EP (1) EP1890671B1 (https=)
JP (1) JP5072833B2 (https=)
KR (1) KR101307910B1 (https=)
CN (1) CN101180028B (https=)
AR (1) AR054361A1 (https=)
AU (1) AU2006248981B2 (https=)
BR (1) BRPI0611289A2 (https=)
CA (1) CA2606567A1 (https=)
IT (1) ITRM20050248A1 (https=)
MX (1) MX2007014222A (https=)
TW (1) TWI365753B (https=)
WO (1) WO2006122883A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109383B2 (ja) * 2007-01-31 2012-12-26 大正製薬株式会社 アダパレン含有外用剤組成物
JP2009137874A (ja) * 2007-12-05 2009-06-25 Authele:Kk ビタミンＣ（Ａｓｃｏｒｂｉｃａｃｉｄ）を含有するレシチンゲルおよびその製造方法
TW201031402A (en) * 2008-12-24 2010-09-01 Sigma Tau Ind Farmaceuti New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
EP3301085A1 (en) * 2016-09-29 2018-04-04 Biogem S.Ca.R.L. Retinoid derivatives with antitumor activity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011808A1 (en) 2001-07-31 2003-02-13 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071923A (en) * 1994-09-16 2000-06-06 Bar-Ilan University Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
FR2752734B1 (fr) * 1996-09-02 1998-11-06 Cird Galderma Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf
US5994330A (en) * 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
BRPI0307550B8 (pt) * 2002-03-12 2021-05-25 Galderma Res & Dev composição farmacêutica em gel tópica, de adapaleno 0,3%

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011808A1 (en) 2001-07-31 2003-02-13 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities

Also Published As

Publication number Publication date
US7635719B2 (en) 2009-12-22
JP2008540603A (ja) 2008-11-20
MX2007014222A (es) 2008-02-07
JP5072833B2 (ja) 2012-11-14
TW200716192A (en) 2007-05-01
AU2006248981A1 (en) 2006-11-23
WO2006122883A9 (en) 2012-10-04
TWI365753B (en) 2012-06-11
CN101180028A (zh) 2008-05-14
AU2006248981B2 (en) 2011-06-02
EP1890671A1 (en) 2008-02-27
BRPI0611289A2 (pt) 2010-08-31
CA2606567A1 (en) 2006-11-23
CN101180028B (zh) 2010-12-08
ITRM20050248A1 (it) 2006-11-21
AR054361A1 (es) 2007-06-20
HK1117737A1 (en) 2009-01-23
KR20080016573A (ko) 2008-02-21
US20080153916A1 (en) 2008-06-26
WO2006122883A1 (en) 2006-11-23
EP1890671B1 (en) 2014-03-05

Similar Documents

Publication Publication Date Title
Vasanth et al. Development and investigation of vitamin C-enriched adapalene-loaded transfersome gel: a collegial approach for the treatment of acne vulgaris
Raza et al. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity
Sinico et al. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle–skin interaction
Rahimpour et al. Liposomes in cosmeceutics
RU2654804C2 (ru) Антиоксидантные композиции и способы их применения
CN102281863B (zh) 集钙作用组合物以及用于治疗皮肤的色素沉着障碍以及病症的方法
JP5570992B2 (ja) 皮膚病又は皮膚病変の治療方法及び組成物
US5411741A (en) Method and composition for skin depigmentation
JP5732471B2 (ja) 溶媒混合物およびビタミンｄ誘導体から成る医薬品組成物または類似体
IL189834A (en) Skin care compositions
JP5112328B2 (ja) 重度の皮膚科障害の局所的処置のための４−オキソ（イソ）トレチノイン
JP2022511270A (ja) シロリムス含有組成物
HK1223297A1 (en) Topical retinoid solutions
KR101307910B1 (ko) 여드름 치료를 위한 아다만틸 메톡시다이페닐 프로페노산의용도
BRPI0714256A2 (pt) composiÇço tàpica, formulaÇço tàpica, mÉtodo para preparar uma composiÇço tàpica, mÉtodo para tratar uma condiÇço de pele, mÉtodo para tratar uma irritaÇço de pele e mÉtodo para fortalecer, firmar, rejuvenescer ou restaurar a condiÇço da pele
RU2450836C1 (ru) Комбинированная мазевая композиция для уменьшения интенсивности локальной гиперпигментации кожи
CN102038954B (zh) 一种适于制备维a酸水溶性制剂的水溶基质
CN117915904A (zh) 包含过氧化苯甲酰和壬二酸的局部制剂及其用途
HK1117737B (en) Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
Naudé Formulation, in vitro release and transdermal diffusion of Vitamin A and Zinc for the treatment of acne
US20240173281A1 (en) Topical compositions containing anthranilic acid derivatives and methods for treating skin disorders
Cunliffe Vitamin a in Dermatology
WO2014109456A1 (ko) 카테킨 또는 그 유도체를 포함하는 모낭각화 이상의 예방 또는 치료용 약학적 조성물

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20160907

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20160907

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000